Beierlein M, Haberle L, Nabieva N, Maass N, et al. Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial. Int J Cancer 2025 Jul 11. doi: 10.1002/ijc.70037.
PMID: 40641449